Business News • PR NewsWire • Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories

Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories

Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories

PARIS and MONTREAL, Oct. 28, 2015 /PRNewswire/ - Ipsen (Euronext: IPN) (ADR: IPSEY) and Telesta Therapeutics Inc. (TSX: TST) (PNK: BNHLF) today announced that they have entered into an exclusive licensing agreement for Ipsen to develop and commercialize MCNA1 for the...

View More : http://www.prnewswire.com/news-releases/telesta-therapeutics-and-ipsen-announce-exclusive-license-agreement-for-mcna1-fo...

Releted News by prnewswire

Georg Jensen Open Flagship Boutique on London's Mount Street

Georg Jansen eröffnet Vorzeige-Boutique in London, Mount Street